PRAME POSITIVE

Clinical trials for PRAME POSITIVE explained in plain language.

Never miss a new study

Get alerted when new PRAME POSITIVE trials appear

Sign up with your email to follow new studies for PRAME POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

First patients to receive new 'ImmTAC' cancer drug in groundbreaking trial

Disease control Recruiting now

This is the first-ever study in people for a new drug called IMC-P115C, designed to treat advanced cancers that have a specific marker called PRAME. The main goal is to test the drug's safety and see if it causes any serious side effects when given alone or with standard treatmen…

Matched conditions: PRAME POSITIVE

Phase: PHASE1 • Sponsor: Immunocore Ltd • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

PRAME POSITIVE

Get alerted when new PRAME POSITIVE trials appear

First patients to receive new 'ImmTAC' cancer drug in groundbreaking trial